IRadimed Corporation
IRMD | NASDAQ
$83.67
+$1.21 (+1.47%)
Sep 22, 2026, 11:52 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 54.96 | 36.18 | 34.90 | 27.74 | 60.80 | 207.27 |
PEG Ratio | 3.34 | 3.08 | 1.05 | 0.81 | 0.10 | -2.38 |
PS Ratio | 14.77 | 9.51 | 9.13 | 6.67 | 13.64 | 8.72 |
PB Ratio | 13.08 | 8.03 | 8.38 | 4.82 | 7.90 | 4.50 |
P/FCF Ratio | 72.03 | 39.55 | 109.62 | 43.51 | 54.25 | 53.35 |
P/OCF Ratio | 49.61 | 27.20 | 44.43 | 35.39 | 50.68 | 47.51 |
OCF/S Ratio | 29.76 | 34.99 | 20.54 | 18.84 | 26.92 | 18.34 |
Debt / Equity Ratio | n/a | 0 | 0.03 | 0.03 | 0.03 | 0.04 |
Quick Ratio | 6.84 | 7.62 | 3.87 | 8.43 | 10.54 | 12.16 |
Current Ratio | 7.98 | 8.84 | 4.65 | 9.06 | 11.18 | 12.96 |
Asset Turnover | 0.77 | 0.74 | 0.71 | 0.62 | 0.50 | 0.45 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | 23.76% | 22.15% | 24.07% | 17.41% | 12.92% | 2.23% |
Return on Assets | 20.67% | 19.56% | 18.66% | 15% | 11.25% | 1.93% |
Return on Invested Capital | 21.02% | 19.34% | 20.78% | 16.04% | 12.19% | 2.53% |
Dividend Yield | 1.22% | 1.96% | 2.21% | 3.53% | n/a | n/a |
Payout Ratio | 66.90% | 71.11% | 76.91% | 97.90% | n/a | n/a |
FCF Payout Ratio | 105.45% | 90.61% | 404.25% | 185.41% | n/a | n/a |
Gross Profit Margin | 76.75% | 76.94% | 76.50% | 77.45% | 76.65% | 74.33% |
Net Profit Margin | 26.82% | 26.26% | 26.22% | 24.07% | 22.30% | 4.32% |
Pretax Profit Margin | 33.84% | 33.14% | 33.16% | 30.36% | 23.52% | -1.94% |
Operating Profit Margin | 31.20% | 29.99% | 30.56% | 29.32% | 23.48% | -2.38% |
FCF Margin | 20.50% | 24.06% | 8.32% | 15.32% | 25.15% | 16.33% |
EBITDA Margin | 36.68% | 34.26% | 34.32% | 31.61% | 26.89% | 1.84% |
Add to Watchlist
Select watchlists to add or remove IRMD